Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

News Briefs: Teleflex Acquires Vidacare; Integra Buys Covidien’s DuraSeal Line

This article was originally published in The Gray Sheet

Executive Summary

Teleflex buys Vidacare Corp. for $262.5 million. Integra LifeSciences acquires Covidien’s Confluent Surgical product line, including the DuraSeal products, for $235 million, plus up to $30 million in milestone payments. W.L. Gore ordered to pay more than $850 million to C.R. Bard to partially resolve a long-running patent dispute. More news.

Advertisement

Related Content

Nightly Home Hemodialysis Gains First FDA Clearance
NxStage Dialysis Needle Technology Gets FDA Nod
Regulatory Briefs: FDA Meetings On Cancer Tests, Glaucoma Devices; DeLauro Questions Device Reclassifications
News Briefs: Boston Sci Settlement; C.R. Bard Scores Patent Victory
$18.4 Million In User Fees Left In CDRH’s Coffers, How Long Will It Last?
Shutdown Realities At FDA: No New Submission Reviews, And More
News In Brief
News In Brief
Baxter Buys Gambro For $4 Billion To Round Out Dialysis Device Lineup

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT032549

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel